ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,272.46
0.82%
Dow Jones
38,991.96
0.40%
Gold vs US Dollar
2,356.545
1.16%
Brent Oil
85.005
0.37%
Bitcoin
64,710.32
-0.41%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. IGM Biosciences Inc (IGMS)

  7. IGM Biosciences Inc (IGMS) News

IGM Biosciences (IGMS)

IGM Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IGMS
DateTimeSourceHeadlineSymbolCompany
20/06/202411:06Edgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:IGMSIGM Biosciences Inc
19/06/202400:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
19/06/202400:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
19/06/202400:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
19/06/202400:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
19/06/202400:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
19/06/202400:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
19/06/202400:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
18/06/202422:00Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:IGMSIGM Biosciences Inc
14/06/202413:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IGMSIGM Biosciences Inc
29/05/202412:00GlobeNewswire Inc.IGM Biosciences to Present at the Jefferies Healthcare ConferenceNASDAQ:IGMSIGM Biosciences Inc
08/05/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IGMSIGM Biosciences Inc
08/05/202421:10GlobeNewswire Inc.IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:IGMSIGM Biosciences Inc
08/05/202421:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IGMSIGM Biosciences Inc
07/05/202412:00GlobeNewswire Inc.IGM Biosciences to Present at the 2024 RBCCM Global Healthcare ConferenceNASDAQ:IGMSIGM Biosciences Inc
17/04/202413:30GlobeNewswire Inc.IGM Biosciences Announces Refocusing of Sanofi CollaborationNASDAQ:IGMSIGM Biosciences Inc
10/04/202412:00GlobeNewswire Inc.IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:IGMSIGM Biosciences Inc
07/03/202421:27Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IGMSIGM Biosciences Inc
07/03/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IGMSIGM Biosciences Inc
07/03/202421:10GlobeNewswire Inc.IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:IGMSIGM Biosciences Inc
06/03/202400:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
01/02/202412:00GlobeNewswire Inc.IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IGMSIGM Biosciences Inc
08/01/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IGMSIGM Biosciences Inc
04/01/202401:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
03/01/202423:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
03/01/202423:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
03/01/202412:00GlobeNewswire Inc.IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IGMSIGM Biosciences Inc
16/12/202300:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
16/12/202300:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
16/12/202300:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:IGMS

Your Recent History

LSE
AAZ
Anglo Asian Mining
LSE
GKP
Gulf Keystone Petroleum
LSE
POS
Plexus
LSE
BIRD
Blackbird
LSE
THG
Thg
LSE
ENET
Ethernity Networks
LSE
POLX
Polarean Imaging
LSE
YOU
Yougov
LSE
GDR
Genedrive
LSE
TERN
Tern
LSE
SRSP
Sirius Petroleum
LSE
LLOY
Lloyds Banking
LSE
OCDO
Ocado
LSE
PANR
Pantheon Resources
LSE
GOLD
LSE
NFDS
Northern Foods
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved